Assessment of medical device regulator COVID-19 policies on entry to market for prioritised devices: a case study
<strong>Background/Aims<br></strong> In response to the COVID-19 pandemic, medical devices were given exceptional use authorisations. Medical device regulators around the world modified their administrative approach to medical device approval to ensure that relevant devices and per...
Автори: | Bergmann, J, Ceross, A |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Mark Allen Healthcare
2023
|
Схожі ресурси
Схожі ресурси
-
Evaluating the presence of software-as-a-medical-device in the Australian Therapeutic Goods Register
за авторством: Ceross, A, та інші
Опубліковано: (2021) -
More than red tape: exploring complexity in medical device regulatory affairs
за авторством: Han, Y, та інші
Опубліковано: (2024) -
More than red tape: exploring complexity in medical device regulatory affairs
за авторством: Yu Han, та інші
Опубліковано: (2024-07-01) -
Tracking the presence of software as a medical device in US Food and Drug Administration databases: Retrospective data analysis
за авторством: Ceross, A, та інші
Опубліковано: (2021) -
Tracking the Presence of Software as a Medical Device in US Food and Drug Administration Databases: Retrospective Data Analysis
за авторством: Aaron Ceross, та інші
Опубліковано: (2021-11-01)